Garg Pushkal bought ALNY
March 2, 2026 · Form 4 insider transaction
Garg Pushkal bought 4,769 shares of Alnylam Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,769
Price
$0.00
Total value
N/A
InsiderGarg Pushkal
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after26,898
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.